Nothing new mate, I started questioning this probably a decade...

First 14 Last

Share
Profile

Follow
Rickaroonie

994 Posts.

126

17/08/18

10:10

Post #: 34989212
Share

Originally posted by BT6487 ↑

Just out of curiosity, can anybody answer me the following questions as info from Austpac is never clear or accurate

- When will be complete Stage 1 of the test work programme?
- How will this be funded? (as it looks like we've pissed the $600k we received from Bergen and Sophs in January down the drain)
- What happened to our patent application lodged in November 2016?

There is now 2Billion shares on issue,no money in the bank, a share price that can't go any lower, no proof of concept and a very real possibility of not being able to raise any funds. And the thing that shíts me the most is the exorbitant amounts we pay in "administration" (aka salaries)

Mike Turbott MUST be replaced. He is incapable of leading us anywhere. He is a liability on all of us. If any other job if you performed as dreadfully as him, you would be shown the door. Colin is doing his best trying to sell our technology to his contacts, the interest is there!! but people want to see it working first. This is where Turbott is letting us down. He's completely inept with project management, procuring and securing. He's had millions and millions and millions of dollars. And still can't get the plant going. We need someone fresh, with more drive, somebody a bit more switched on. I really hope shareholders club together at the AGM and let these feelings be known. Enough is enough

Expand

Nothing new mate, I started questioning this probably a decade (maybe longer) ago. Yea, really happy with MT, NOT! He's been on a good (make that FANTASTIC) wicket for way too long.

APG Price at posting: 0.1¢ Sentiment: None Disclosure: Held
4 Upvote

1 Great analysis

Reply

Top Stories

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

PL3

Patagonia looks to raise $2.15M for South American exploration and development

TLS

Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 29 more messages in this thread...

First 14 Last

Add APG (ASX) to my watchlist

Nothing new mate, I started questioning this probably a decade...

Top Stories

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News